XEME Biopharma Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma (NCT02194751) | XEME Biopharma Inc. | 2021-07-01 |
Track XEME Biopharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.